Roth Mkm Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN - Get Free Report) had its price target lowered by stock analysts at Roth Mkm from $36.00 to $31.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the construction company's stock. Roth Mkm's price target suggests a potential upside of 88.11% from the company's previous close.

ASPN has been the topic of several other research reports. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a report on Thursday, October 31st. HC Wainwright reiterated a "buy" rating and set a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Benchmark restated a "buy" rating and issued a $14.00 price objective on shares of Aspen Aerogels in a report on Thursday, August 8th. Piper Sandler reduced their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a report on Tuesday, October 22nd. Finally, TD Cowen boosted their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a "buy" rating in a research note on Tuesday, August 20th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Aspen Aerogels has a consensus rating of "Moderate Buy" and an average price target of $28.90.

Aspen Aerogels Trading Down 1.7 %

Shares of NYSE ASPN traded down $0.29 during mid-day trading on Friday, reaching $16.48. 4,212,197 shares of the company's stock were exchanged, compared to its average volume of 1,570,836. The company's 50-day moving average is $23.10 and its 200-day moving average is $24.61. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. The firm has a market capitalization of $1.27 billion, a price-to-earnings ratio of -1,646.35 and a beta of 2.21. Aspen Aerogels has a 52-week low of $8.76 and a 52-week high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The business had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. During the same period in the previous year, the firm earned ($0.22) EPS. The business's revenue was up 144.4% on a year-over-year basis. Analysts expect that Aspen Aerogels will post 0.1 EPS for the current fiscal year.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company's stock, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the business's stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company's stock, valued at $14,523,709.20. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently bought and sold shares of ASPN. Quest Partners LLC boosted its holdings in shares of Aspen Aerogels by 263.3% in the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock valued at $205,000 after acquiring an additional 5,361 shares during the period. Sargent Investment Group LLC raised its position in Aspen Aerogels by 1.8% in the 3rd quarter. Sargent Investment Group LLC now owns 323,369 shares of the construction company's stock valued at $8,954,000 after purchasing an additional 5,830 shares during the last quarter. Black Swift Group LLC raised its position in Aspen Aerogels by 34.1% in the 3rd quarter. Black Swift Group LLC now owns 106,500 shares of the construction company's stock valued at $2,949,000 after purchasing an additional 27,100 shares during the last quarter. Oppenheimer & Co. Inc. boosted its stake in Aspen Aerogels by 167.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company's stock worth $2,839,000 after purchasing an additional 64,154 shares during the period. Finally, Peregrine Asset Advisers Inc. purchased a new position in Aspen Aerogels during the 3rd quarter worth $1,520,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.